Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06226558 · ClinicalTrials.gov registry record
Long-Term Outcomes of Children With Congenital CMV in New York State
A clinical trial of Sensorineural Hearing Loss and Congenital CMV Infection, sponsored by Stony Brook University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06226558 is a study of Sensorineural Hearing Loss and Congenital CMV Infection that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 1,000 participants, above the 54-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (1752% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06226558, a study of Sensorineural Hearing Loss and Congenital CMV Infection, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
PROACTIVE NYS is a long-term follow-up study of all infants who test positive for congenital Cytomegalovirus infection (CMV) throughout New York State on the Newborn Screen. By following all infants who screen positive, we will learn important information about the range of symptoms caused by congenital CMV, from those babies with more severe findings to those with no symptoms. In particular, our study will provide new information about many facets of congenital CMV, including: * Developmental, hearing, neurologic, and vision outcomes * The spectrum and timing of symptoms * The impact congenital CMV has on the baby and its family * How many babies are infected with congenital CMV in New York State How antiviral medications and other interventions impact outcomes of children with congenital CMV Throughout the duration of the study, children will undergo routine developmental and hearing assessments, which will assist with early diagnosis of any infection complications. Any child found to have a neurodevelopmental, hearing, or vision abnormality will be referred for appropriate evaluation and treatment. Families will also be asked to complete periodic surveys about their experience with congenital CMV, both as a medical diagnosis and as it affects their day-to-day activities.
Conditions Studied
Study Locations (1)
New York
- Stony Brook Children's Hospital - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2026-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06226558
The ClinicalTrials.gov registry entry for NCT06226558 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (1752% higher). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 0 interventions.
NCT06226558 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06226558 about?
NCT06226558 is a clinical study titled "Long-Term Outcomes of Children With Congenital CMV in New York State". PROACTIVE NYS is a long-term follow-up study of all infants who test positive for congenital Cytomegalovirus infection (CMV) throughout New York State on the Newborn Screen. By following all infants who screen positive, we will learn important information about the range of symptoms caused by congen...
What is the current status of trial NCT06226558?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-02-01. Estimated completion is 2026-10-01.
What conditions does trial NCT06226558 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Congenital CMV Infection.
Who is sponsoring clinical trial NCT06226558?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06226558 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
RECRUITING · NA
-
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
RECRUITING
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
RECRUITING
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.